JPS5924972B2 - Process for producing chalcone ethers - Google Patents
Process for producing chalcone ethersInfo
- Publication number
- JPS5924972B2 JPS5924972B2 JP2472075A JP2472075A JPS5924972B2 JP S5924972 B2 JPS5924972 B2 JP S5924972B2 JP 2472075 A JP2472075 A JP 2472075A JP 2472075 A JP2472075 A JP 2472075A JP S5924972 B2 JPS5924972 B2 JP S5924972B2
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- chalcone
- group
- butenyloxy
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
【発明の詳細な説明】
本発明は、抗消化性潰瘍活性を有する新規なカルコンエ
ーテル類の製法に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for producing novel chalcone ethers having anti-peptic ulcer activity.
更に詳しくは、一般式X ′ Y″ べ(I)
〔式中、X1、X2およびX3は、このうちの任意の1
個は一般式1t2
(式中、R1およびR2は同一であつて低級アルキル基
もしくはアリル基を示すか、または隣接する窒素原子と
ともにピペリジメノ基を形成することを示す。More specifically, the general formula
represents the general formula 1t2 (wherein R1 and R2 are the same and represent a lower alkyl group or an allyl group, or together with the adjacent nitrogen atom, they form a piperidimeno group).
nは2または3である。)にて表わされるジ置換アミノ
(又はピペリジノ)アルコキシ基を示し、その余は式に
て表わされる3−メチル−2−ブテニロキシ基または水
素原子を示すが、このうちの少なくとも1個は3−メチ
ル−2−ブテニロキシ基を示すことを条件とする。n is 2 or 3. ) represents a di-substituted amino (or piperidino) alkoxy group, and the remainder represents a 3-methyl-2-butenyloxy group or a hydrogen atom represented by the formula, at least one of which is 3-methyl The condition is that it represents a -2-butenyloxy group.
Y1およびY2は、水酸基または水素原子を示す。〕に
て表わされるカルコンエーテル類またはその塩類を製造
するに当り、一般にて表わされる化合物と一般式(上記
の(1)および(の式中、X,,X2,X3,Ylおよ
びY2は前記のものと同意義である。Y1 and Y2 represent a hydroxyl group or a hydrogen atom. ] In producing chalcone ethers or salts thereof, a compound generally represented by the general formula ((1) and (in the above formulas, X, , X2, X3, Yl and Y2 are It has the same meaning as ``thing''.
)にて表わされる化合物とを結合させること、もしくは
更にこの生成する縮合物を酸処理してその塩を製造する
ことを特徴とするカルコンエーテル類の製法に関するも
のである。本発明方法における縮合に当つては、化合物
(IV)と化合物(との混合物をエタノール,メタノー
ル,イソプロパノールなどの有機溶媒もしくはこれらの
含水物に溶解または懸濁させ、これを苛性カリ、苛件ソ
ーダ、ナトリウムエチラートなどのアルカリまたは塩化
水素、硫酸などの縮合助剤の存在下に室温もしくは加熱
下に反応させる。This invention relates to a process for producing chalcone ethers, which is characterized by combining the compounds represented by (1) and (2) or further acid-treating the resulting condensate to produce a salt thereof. In the condensation in the method of the present invention, a mixture of compound (IV) and the compound is dissolved or suspended in an organic solvent such as ethanol, methanol, isopropanol, or a water-containing substance thereof, and this is dissolved or suspended in an organic solvent such as ethanol, methanol, isopropanol, etc. The reaction is carried out at room temperature or under heating in the presence of an alkali such as sodium ethylate or a condensation aid such as hydrogen chloride or sulfuric acid.
得られる縮合物を酸処理、たとえばマレイン酸,フマー
ル酸,コハク酸,シユウ酸,マロン酸などの有機酸,ま
たは硫酸,硝酸,臭化水素などの無機酸で処理すること
によりこれらの酸付加塩を得ることができる。なお、式
()で表わされるジ置換アミノアルコキシ基のR1およ
びR2における低級アルキル基はメチルまたはエチル基
を意味する。These acid addition salts can be prepared by treating the resulting condensate with an acid, for example an organic acid such as maleic acid, fumaric acid, succinic acid, oxalic acid, malonic acid, or an inorganic acid such as sulfuric acid, nitric acid, or hydrogen bromide. can be obtained. In addition, the lower alkyl group in R1 and R2 of the di-substituted aminoalkoxy group represented by formula () means a methyl or ethyl group.
化合物(IV)または()における式()または()の
基を導入するに当つては、公知方法たとえば特公昭42
−19590号公報もしくは後記実施例の記載方法また
はヘミツシユ ベリヒテ、出,3511(1972)の
記載方法による。すなわち、ジ置換アミノ(又はピペリ
ジノ)アルキルクロリドを相当するハイドロキシアセト
フエノンまたはハイドロキシベンズアルデヒドとを反応
させることによつて式()の基が導入され、また3−メ
チル−2−ブテニルプロミドを相当するハイドロシアセ
トフエノンまたはハイドロキシベンズアルデヒドと反応
させることによつて式()の基を導入させることができ
る。本発明方法で得られる化合物は、抗消化性潰瘍活性
を有し、また酸付加塩を形成した化合物は親水性が強い
。表1にラツトに対する幽門結紮法(腹腔内投与、15
時間法)による潰瘍抑制効果を示す。また、実帷例4の
化合物は酢酸潰瘍法(ラツト10匹、50即/Kg、経
口、10日間)による潰瘍治癒率は48.301)であ
つた。When introducing a group of formula () or () into compound (IV) or (), known methods such as Japanese Patent Publication No. 42
-19590 or the method described in the Examples described later, or the method described in Hemitsu Berichte, Vol. 3511 (1972). That is, the group of formula () is introduced by reacting a disubstituted amino (or piperidino) alkyl chloride with the corresponding hydroxyacetophenone or hydroxybenzaldehyde, and 3-methyl-2-butenyl bromide is reacted with the corresponding hydroxyacetophenone or hydroxybenzaldehyde. A group of formula () can be introduced by reaction with russacetophenone or hydroxybenzaldehyde. The compound obtained by the method of the present invention has antipeptic ulcer activity, and the compound formed into an acid addition salt has strong hydrophilicity. Table 1 shows the pylorus ligation method for rats (intraperitoneal administration, 15
It shows the ulcer suppressing effect using the time method). Furthermore, the compound of Practical Example 4 had an ulcer healing rate of 48.301) using the acetic acid ulcer method (10 rats, 50 rats/Kg, orally for 10 days).
次に実施例を示す。Next, examples will be shown.
実施例 1
パラハイドロキシベンズアルデヒド18.69を常法に
よりナトリウム塩とし、これに無水トルエン300m1
とN,N−ジメチルアミノエチルクロリド26.19を
加え、混合液を3.5時間還流後、蒸留して4−(N,
N−ジメチルアミノエトキシ)ベンズアルデヒド(VD
22.99を得た。Example 1 18.69% of parahydroxybenzaldehyde was made into a sodium salt by a conventional method, and 300ml of anhydrous toluene was added to this.
and 26.19 g of N,N-dimethylaminoethyl chloride were added, and the mixture was refluxed for 3.5 hours, then distilled to give 4-(N,
N-dimethylaminoethoxy)benzaldehyde (VD
22.99 was obtained.
BplO4.5lO6.5デC(0.2關Hg)。4−
(3−メチル−2−ブテニロキシ)アセトフエノン2.
59と上記の化合物VI2.49をエタノール10m1
に溶かし、50%苛性カリ209を加え、室温で5.5
時間撹拌した。BplO4.5lO6.5 deC (0.2 degrees Hg). 4-
(3-Methyl-2-butenyloxy)acetophenone2.
59 and the above compound VI2.49 in 10 ml of ethanol.
Add 50% caustic potash 209 to 5.5% at room temperature.
Stir for hours.
希塩酸を加えPH8とし、メチレンクロライドで抽出、
溶媒を留去後イソプロピルアルコールで再結晶して無色
針状晶の4−(N,N−ジメチルアミノエトキシ)4′
−(3−メチル−2−ブテニロキシ)カルコン3.59
を得た。Mp8l,5−82。0カC実施例 2
実帷例1で得た4−(N,N−ジメチルアミノエトキシ
)−4′−(3−メチル−2−ブテニロキシ)カルコン
3.59をアセトン20wL1に溶かし、これにアセト
ン20m1に溶かしたマイレン酸1.19を加え室温に
放置後、析出物をヘキサン・アセトン混液で再結晶して
無色針状晶の4−(N,N−ジメチルアミノエトキシ)
−4′一(3−メチル2−ブテニロキシ)カルコンマレ
・イン酸3.99を得た。Add dilute hydrochloric acid to pH 8, extract with methylene chloride,
After distilling off the solvent, recrystallization from isopropyl alcohol yields colorless needle-like crystals of 4-(N,N-dimethylaminoethoxy)4'
-(3-methyl-2-butenyloxy)chalcone 3.59
I got it. Mp8l, 5-82.0 C Example 2 3.59 liters of 4-(N,N-dimethylaminoethoxy)-4'-(3-methyl-2-butenyloxy)chalcone obtained in Practical Example 1 was dissolved in 20wL1 of acetone. To this was added 1.19 ml of maleic acid dissolved in 20 ml of acetone, and after leaving it at room temperature, the precipitate was recrystallized from a hexane-acetone mixture to give colorless needle-like crystals of 4-(N,N-dimethylaminoethoxy).
-4'-(3-methyl-2-butenyloxy)chalcone male inic acid 3.99% was obtained.
Mpl34.O−134レC実施例 3
2−ハイドロキシ−4−(3−メチル−2−ブテニロキ
シ)アセトフエノン2.79と化合物2.49をエタノ
ール10m1に溶かし、これに50%苛性カリ溶液20
9を加え、室温で6時間撹拌した。Mpl34. O-134ReC Example 3 Dissolve 2.79 of 2-hydroxy-4-(3-methyl-2-butenyloxy)acetophenone and 2.49 of the compound in 10 ml of ethanol, and add 20 ml of 50% caustic potassium solution to this.
9 was added and stirred at room temperature for 6 hours.
希塩酸を加えPH8とし、メチレンクロライドで抽出、
イソプロピルアルコールで再結晶して黄色針状晶の2/
−ハイドロキシ−4−(N,N−ジメチルアミノエトキ
シ)−4′−(3−メチル2−ブテニロキシ)カルコン
3.39を得た。Mp82.O−82.5コC実施例
4
実施例3で得た2′−ハイドロキシ−4−(N,N−ジ
メチルアミノエトキシ)−4′−(3−メチル−2−ブ
テニロキシ)カルコン2.09をアセトン10m1に溶
かし、これにアセトン10m1に溶かしたマレイン酸0
.69を加え、得られた結晶をヘキサン・アセトン混液
で再結晶して黄色針状晶の2′−ハイドロキシ−4−(
N,N−ジメチルアミノエトキシ)−4/一(3−メチ
ル−2−ブテニロキシーカルコンマレイン酸1.99を
得た。Add dilute hydrochloric acid to pH 8, extract with methylene chloride,
Recrystallize with isopropyl alcohol to obtain 2/2 yellow needle crystals.
-Hydroxy-4-(N,N-dimethylaminoethoxy)-4'-(3-methyl-2-butenyloxy)chalcone 3.39 was obtained. Mp82. O-82.5coC example
4 Dissolve 2.09 of 2'-hydroxy-4-(N,N-dimethylaminoethoxy)-4'-(3-methyl-2-butenyloxy)chalcone obtained in Example 3 in 10 ml of acetone, and add 10 ml of acetone to this. Maleic acid dissolved in
.. 69 was added, and the obtained crystals were recrystallized from a hexane-acetone mixture to give yellow needle-like crystals of 2'-hydroxy-4-(
1.99% of N,N-dimethylaminoethoxy)-4/1(3-methyl-2-butenyloxychalcone maleic acid) was obtained.
Mpl3l.O−132イC実施例 5
4−(N,N−ジメチルアミノエトキシ)アセトフエノ
ン〔Bpl27.O−132.5アC(0.6m77t
−1g)〕2.69と4−(3−メチル−2−ブテニロ
キシ)ベンズアルデヒド2.4f!をエタノール10m
1に溶かし、これに50%苛性カリ溶液209を加え、
室温で7.5時間撹拌した。Mpl3l. O-132IC Example 5 4-(N,N-dimethylaminoethoxy)acetophenone [Bpl27. O-132.5AC (0.6m77t
-1g)] 2.69 and 4-(3-methyl-2-butenyloxy)benzaldehyde 2.4f! 10m of ethanol
1, add 50% caustic potassium solution 209,
Stirred at room temperature for 7.5 hours.
希塩酸を加えPH8とし、メチレンタロライドで抽出、
イソプロパノールで再結晶して淡黄色針状晶の4′−(
N,N−ジメチルアミノエトキシ)−4−(3−メチル
−2ブテニロキシ)カルコン3.39を得た。Mp85
.5−86.5コC次に、このカルコンに実帷例2と同
様の方法で、マレイン酸を付加しアセトン・ヘキサン混
液で再結晶して淡黄色針状晶の4′−(N,N−ジメチ
ルアミノエトキシ)−4−(3−メチル−2−ブテニロ
キシ)カルコンマイレン酸塩を得た。Add dilute hydrochloric acid to pH 8, extract with methylenetalolide,
Recrystallization from isopropanol gave pale yellow needle-like crystals of 4'-(
3.39% of N,N-dimethylaminoethoxy)-4-(3-methyl-2butenyloxy)chalcone was obtained. Mp85
.. 5-86.5 CoCNext, maleic acid was added to this chalcone in the same manner as in Practical Example 2, and recrystallized from an acetone/hexane mixture to give pale yellow needle crystals of 4'-(N,N -dimethylaminoethoxy)-4-(3-methyl-2-butenyloxy)chalcone maleate was obtained.
Mpl87.5−188.5レC実帷例 6
4−(3−メチル−2−ブテニロキシ)アセトフエノン
4.49と4−(N,N−ジメチルアミノプロピロキシ
)ベンズアルデセド〔Bpll5−12『C(0.3m
w!Hg)〕4.559をエタノール18111に溶か
し、これに50(Fb苛姓ソーダ溶液369を加え、3
0℃で3時間撹拌した。Mpl87.5-188.5ReC practical example 6 4-(3-methyl-2-butenyloxy)acetophenone 4.49 and 4-(N,N-dimethylaminopropyloxy)benzaldeced [Bpll5-12'C(0 .3m
Lol! Hg)] 4.559 was dissolved in ethanol 18111, 50 (Fb caustic soda solution 369 was added to it,
Stirred at 0°C for 3 hours.
希塩酸を加えPH8とし、メチレンクロライドで抽出、
アセトン・ヘキサン混液で再結晶して淡黄色板状晶の4
′−(3−メチル−2−ブテニロキシ)−4−(N,N
−ジメチルアミノプロピロキシ)カルコン7.69を得
た。Mp69−71キC次にこのカルコン実施例2と同
様の方法でマイレン酸を付加し、ヘキサン・アセトン混
液で再結晶して淡黄色板状晶の4′一(3−メチル−2
−ブテロニキシ)4−4(N,N−ジメチルアミノプロ
キシ)カルコンマレイン酸塩を得た。Add dilute hydrochloric acid to pH 8, extract with methylene chloride,
Recrystallize with a mixture of acetone and hexane to obtain pale yellow plate-like crystals 4.
'-(3-methyl-2-butenyloxy)-4-(N,N
-dimethylaminopropyloxy)chalcone 7.69% was obtained. Mp69-71 KiC Next, maleic acid was added to this chalcone in the same manner as in Example 2, and recrystallized from a hexane-acetone mixture to give pale yellow plate-like crystals of 4'-(3-methyl-2
-buteronyloxy)4-4(N,N-dimethylaminoproxy)chalcone maleate was obtained.
Mpll8.5−119.5ンC実施例 7
4−(N,N−ジメチルアミノプロピロキシ)アセトフ
エノン〔Bpl35−13645シC(0.5mmHg
)〕159と4−(3−メチル−2−ブテニロキシ)ベ
ンズアルデヒド13.19をエタノール56m1に溶か
し、これに50%苛性カリ溶液1129を加え、室温で
5時間撹拌した。Mpll8.5-119.5C Example 7 4-(N,N-dimethylaminopropyloxy)acetophenone [Bpl35-13645C (0.5mmHg
)] 159 and 4-(3-methyl-2-butenyloxy)benzaldehyde 13.19 were dissolved in 56 ml of ethanol, 50% caustic potassium solution 1129 was added thereto, and the mixture was stirred at room temperature for 5 hours.
希塩酸を加え、PH8とし、メチレンクロライドで抽出
、イソプロパノールで再結晶して淡黄色針状晶の4(3
−メチル−2−ブテニロキシ)4′−(N,N−ジメチ
ルアルミノプロピロキシ)カルコン7.79を得た。M
p82.5−83.5コC次に、このカルコン7.5g
に実施例2と同様の方法でマレイン酸を付加し、アセト
ン・ヘキサン混液で再結晶して白色無定形抽の4−(3
−メチル−2−ブテニロキシ)−4′−(N,N−ジメ
チルアミノプロピロキシ)カルコンマレイン酸塩7.4
f1を得た。Mpll4.5−115)C実施例 84
−(N,N−ジメチルアミノプロピロキシ)アセトフエ
ノン12.09と2−(3−メチル−2ーブテニロキシ
)ベンズアルデヒド10.6gを46Tf11のエタノ
ールに溶かし、これに50%苛性カリ溶液929を加え
、室温で3時間撹拌した。Add dilute hydrochloric acid to adjust the pH to 8, extract with methylene chloride, and recrystallize with isopropanol to obtain pale yellow needle-like crystals of 4 (3
-Methyl-2-butenyloxy)4'-(N,N-dimethylaluminopropyloxy)chalcone 7.79% was obtained. M
p82.5-83.5coC Next, 7.5g of this chalcone
Maleic acid was added to the 4-(3
-methyl-2-butenyloxy)-4'-(N,N-dimethylaminopropyloxy)chalcone maleate 7.4
I got f1. Mpll4.5-115)C Example 84
-(N,N-dimethylaminopropyloxy)acetophenone 12.09 and 2-(3-methyl-2-butenyloxy)benzaldehyde 10.6g were dissolved in 46Tf11 of ethanol, 50% caustic potassium solution 929 was added thereto, Stir for hours.
希塩酸を加え、PH8とし、メチレンクロライドで抽出
、溶媒留去後、シリカゲルカラムクロマトグラフイ一に
付し、黄色油状の2−(3−メチル2−ブテニロキシ)
−4′−(N,N−ジメチルアミノプロピロキシ)カル
コン〔Bpl33一136プC(0.1W!W!Hg)
〕8.19を得た。次に、このカルコン8.09に実施
例2と同様の方法でマレイン酸を付加し、減圧蒸留して
7.3gの2−(3−メチル−2−ブテニロキシ)−4
′−(N,N−ジメチルアミノプロピロキシ)カルコン
マレイン酸塩を得た。Bpl4O〜142ルC(0.0
9m7!LHg)実梅例 9
4−(N,N−ジメチルアミノエトキシ)アセトフエノ
ン4.19と4−ゲラニロキシ ベンズアルデヒド4.
5f!を20dのエタノールに溶解し、これに50%苛
性カリ溶液409を加え、50℃で1,5時間撹拌した
。Add dilute hydrochloric acid to adjust the pH to 8, extract with methylene chloride, evaporate the solvent, and apply silica gel column chromatography to obtain 2-(3-methyl-2-butenyloxy) as a yellow oil.
-4'-(N,N-dimethylaminopropyloxy)chalcone [Bpl33-136PC (0.1W!W!Hg)
] 8.19 was obtained. Next, maleic acid was added to 8.09 of this chalcone in the same manner as in Example 2, and distilled under reduced pressure to give 7.3 g of 2-(3-methyl-2-butenyloxy)-4.
'-(N,N-dimethylaminopropyloxy)chalcone maleate was obtained. Bpl4O~142C (0.0
9m7! LHg) Fruit Example 9 4-(N,N-dimethylaminoethoxy)acetophenone 4.19 and 4-geranyloxybenzaldehyde 4.
5f! was dissolved in 20 d of ethanol, 50% caustic potassium solution 409 was added thereto, and the mixture was stirred at 50° C. for 1.5 hours.
希硫酸でPH8とし、メチレンクロライドで抽出し、溶
媒留去後、シリカゲルカラムクロマトグラフイ一に付し
、油状の4−ゲラニロキシ一4′−(N,N−ジエチル
アミノエトキシ)カルコン5.19を得た。Bpl45
.O〜147.0℃(0,09mmHg)次に、このカ
ルコン5.0f!に実細例2と同様の方法でマレイン酸
を付加し、減圧蒸留して4.29の4−ゲラニロキシ一
4′−(N,N−ジエチルアミノエトキシ)カルコンマ
レイン酸塩を得た。The pH was adjusted to 8 with dilute sulfuric acid, extracted with methylene chloride, and after distilling off the solvent, it was subjected to silica gel column chromatography to obtain 5.19 of an oily 4-geranyloxy-4'-(N,N-diethylaminoethoxy)chalcone. Ta. Bpl45
.. O ~ 147.0°C (0.09mmHg) Next, this chalcone 5.0f! Maleic acid was added to the mixture in the same manner as in Example 2, and distilled under reduced pressure to obtain 4.29 4-geranyloxy-4'-(N,N-diethylaminoethoxy)chalcone maleate.
Bpl47〜150℃(0.09mmHg)実施例 1
04−(N,N−ジアリルアミノエトキシ)アセトフエ
ノン4.99と2,4−ビス(3−メチル−2一ブテニ
ロキシ)ベンズアルデヒド5.29を20m1のエタノ
ールに溶解、これに50%苛性カリ溶液409を加え、
室温で5時間撹拌した。Bpl47-150℃ (0.09mmHg) Example 1
04-(N,N-diallylaminoethoxy)acetophenone 4.99 and 2,4-bis(3-methyl-2-butenyloxy)benzaldehyde 5.29 were dissolved in 20 ml of ethanol, and 50% caustic potassium solution 409 was added thereto. ,
Stirred at room temperature for 5 hours.
希塩酸でPH8とし、メチレンクロライドで抽出し、溶
媒留去後シリカゲルカラムクロマトグラフイ一に付し油
状の2,4−ビス(3−メチル−2−ブテニロキシ)−
4′−(N,N−ジアリルアミノエトキシ)カルコン6
.3f!を得た。Bpl33〜135℃(0.0871
LmHg)次に、このカルコン6,09に実施例2と同
様の方法でマロン酸を付加し減圧蒸留して5.19の2
,4−ビス(3−メチル−2−ブテニロキシ)−4′(
N,N−ジアリルアミノエトキシ)カルコンマロン酸塩
を得た。The pH was adjusted to 8 with dilute hydrochloric acid, extracted with methylene chloride, and after distilling off the solvent, it was subjected to silica gel column chromatography to obtain an oily 2,4-bis(3-methyl-2-butenyloxy)-
4'-(N,N-diallylaminoethoxy)chalcone 6
.. 3f! I got it. Bpl33~135℃ (0.0871
(LmHg) Next, malonic acid was added to this chalcone 6,09 in the same manner as in Example 2 and distilled under reduced pressure to obtain 5.19-2.
,4-bis(3-methyl-2-butenyloxy)-4'(
N,N-diallylaminoethoxy)chalcone malonate was obtained.
Bpl34〜136)C(0,06m1Hg)実施例
11
4−(3−メチル−2−ブテニロキシ)アセトフエノン
5.19と4−(N,N−ジエチルアミノエトキシ)ベ
ンズアルデヒド5.69を20m1のエタノールに溶解
、これに50%苛性カリ溶液409を加え、室温で5時
間撹拌した。Bpl34-136) C (0,06mlHg) Example
11 Dissolve 5.19 of 4-(3-methyl-2-butenyloxy)acetophenone and 5.69 of 4-(N,N-diethylaminoethoxy)benzaldehyde in 20 ml of ethanol, add 50% caustic potassium solution 409, and dissolve at room temperature. Stirred for 5 hours.
希塩酸でPHを8とし、メチレンクロライドで抽出し、
イソプロパノールで再結晶して白色針状晶の4−(N,
N−ジエチルアミノエトキシ)−4′−(3−メチル−
2−ブテニロキシ)カルコン(Mp69.O〜7rC)
6.29を得た。このカルコン6.09に実施例2の方
法でマレイン酸を付加し、アセトンで再結晶して白色針
状晶5.8f!の4−(N,N−ジエチルアミノエトキ
シ)−4′−(3−メチル−2ブテニロキシ)カルコン
マレイン酸塩を得た。MplO7〜108コC実施例
12
4−(2−ピペリジノエトキシ)アセトフエノン5.5
9と4−(3−メチル−2−ブテニロキシ)ベンズアル
デヒド4.59を20m1のエタノールに溶解、これに
50%苛性カリ溶液409を加え、室温で3時間撹拌し
た。Adjust the pH to 8 with dilute hydrochloric acid, extract with methylene chloride,
Recrystallization from isopropanol gives white needle-like crystals of 4-(N,
N-diethylaminoethoxy)-4'-(3-methyl-
2-butenyloxy) chalcone (Mp69.O~7rC)
6.29 was obtained. Maleic acid was added to this chalcone 6.09 by the method of Example 2, and recrystallized with acetone to give a white needle-like crystal of 5.8f! 4-(N,N-diethylaminoethoxy)-4'-(3-methyl-2butenyloxy)chalcone maleate was obtained. MplO7-108C example
12 4-(2-piperidinoethoxy)acetophenone 5.5
9 and 4.59 of 4-(3-methyl-2-butenyloxy)benzaldehyde were dissolved in 20 ml of ethanol, 50% caustic potassium solution 409 was added thereto, and the mixture was stirred at room temperature for 3 hours.
希塩酸でPHを8とし、メチレンクロライドで抽出し、
シリカゲルカラムクロマトグラフイ一に付し、油状の4
−(3−メチル−2−ブテニロキシ)−4′一(2−ピ
ペリジノエトキシ)カルコン7.49を得た。Bpl4
O〜141シC(0.0871t1LHg)このカルコ
ン7.09にアセトンに溶解したマレイン酸を加え、減
圧蒸留して6.19の4−(3ーメチル−2−ブテニロ
キシ)−4′−(2−ピペリジノエトキシ)カルコンマ
レイン酸塩を得た。Adjust the pH to 8 with dilute hydrochloric acid, extract with methylene chloride,
The oil was subjected to silica gel column chromatography.
-(3-Methyl-2-butenyloxy)-4'-1(2-piperidinoethoxy)chalcone 7.49 was obtained. Bpl4
O ~ 141C (0.0871t1LHg) Maleic acid dissolved in acetone was added to this chalcone 7.09 and distilled under reduced pressure to obtain 6.19 4-(3-methyl-2-butenyloxy)-4'-(2- Piperidinoethoxy) chalcone maleate was obtained.
Claims (1)
_1、X_2およびX_3は、このうちの任意1個は一
般式▲数式、化学式、表等があります▼(II)(式中、
R_1およびR_2は、同一であつて低級アルキル基も
しくはアリル基を示すか、または隣接する窒素原子とと
もにピペリジノ基を形成することを示す。 nは2また3である。)にて表わされるジ置換アミノ(
又はピペリジノ)アルコキシ基を示し、その余は式▲数
式、化学式、表等があります▼(III)にて表わされる
3−メチル−2−ブテニロキシ基または水素原子を示す
が、このうちの少なくとも1個は3−メチル−2−ブテ
ロニキシ基を示すことを条件とする。 Y_1およびY_2は水酸基または水素原子を示す。〕
にて表わされるカルコンエーテル類またはその塩類を製
造するに当り、一般式▲数式、化学式、表等があります
▼(IV)にて表わされる化合物と一般式 ▲数式、化学式、表等があります▼(V)(上記の(I
V)および(V)の式中、X_1、X_2、X_3、Y
_1およびY_2は前記のものと同意義である。 )にて表わされる化合物とを縮合させること、もしくは
更にこの生成する縮合物を酸処理してその塩を製造する
ことを特徴とするカルコンエーテル類の製法。[Claims] 1. General formula▲There are mathematical formulas, chemical formulas, tables, etc.▼(I) [In the formula,
_1, X_2 and
R_1 and R_2 are the same and represent a lower alkyl group or an allyl group, or represent a piperidino group together with adjacent nitrogen atoms. n is 2 or 3. ) for di-substituted amino (
or piperidino)alkoxy group, and the remainder represents a 3-methyl-2-butenyloxy group or a hydrogen atom represented by the formula ▲ Numerical formula, chemical formula, table, etc. ▼ (III), but at least one of these represents represents a 3-methyl-2-buteronoxy group. Y_1 and Y_2 represent a hydroxyl group or a hydrogen atom. ]
In producing chalcone ethers or their salts represented by (IV), there are general formulas ▲ mathematical formulas, chemical formulas, tables, etc. ▼ (IV) and general formulas ▲ mathematical formulas, chemical formulas, tables, etc. V) ((I
V) and (V), X_1, X_2, X_3, Y
_1 and Y_2 have the same meanings as above. ) or further acid-treating the resulting condensate to produce a salt thereof.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2472075A JPS5924972B2 (en) | 1975-02-28 | 1975-02-28 | Process for producing chalcone ethers |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2472075A JPS5924972B2 (en) | 1975-02-28 | 1975-02-28 | Process for producing chalcone ethers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS51100050A JPS51100050A (en) | 1976-09-03 |
| JPS5924972B2 true JPS5924972B2 (en) | 1984-06-13 |
Family
ID=12145983
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2472075A Expired JPS5924972B2 (en) | 1975-02-28 | 1975-02-28 | Process for producing chalcone ethers |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5924972B2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS628368U (en) * | 1985-06-28 | 1987-01-19 |
-
1975
- 1975-02-28 JP JP2472075A patent/JPS5924972B2/en not_active Expired
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS628368U (en) * | 1985-06-28 | 1987-01-19 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS51100050A (en) | 1976-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4065584A (en) | Sulphur containing arylamine derivatives | |
| JPH0597768A (en) | Production of intermediate for producing alkoxyiminoacetoamide compounds and intermediate used therefor | |
| JPS61207369A (en) | Benzoic acid intermediate having three substituents | |
| JPH01125339A (en) | Production of 1, 4-bis (2, 2, 2- trifluoroethoxy)benzene | |
| US5239077A (en) | Highly pure amidoximes | |
| CN107428648B (en) | Process for the preparation of compounds such as 3-arylbutyraldehyde useful for the synthesis of medetomidine | |
| JPS5924972B2 (en) | Process for producing chalcone ethers | |
| US5089654A (en) | Chalcone derivatives | |
| CA2628921C (en) | Process for the preparation of delmopinol and derivatives thereof | |
| US2606195A (en) | Aryl pyridyl carbinol ethers | |
| US6043371A (en) | Organic compound synthesis | |
| PL191371B1 (en) | Method of obtaining pyridin-2,3-dicarboxylate compounds, intermediate compounds used in their production and method of obtaining such intermediate compounds | |
| HUT56054A (en) | Process for the production of propanamide derivatives and medical preparations containing such compounds | |
| US3855296A (en) | CYCLO-SUBSTITUTED-1-p({107 -AMINOALKOXY) PHENYL CYCLOHEXANES | |
| EP0292735A1 (en) | Process for preparing alpha-(alkylphenyl)-4-(hydroxydiphenylmethyl)-1-piperidine butanol | |
| KR20170006311A (en) | Method of producing trisphenol derivatives | |
| Shriner et al. | Benzopyrylium Salts. III. Syntheses from Substituted Coumarins and Chromones | |
| Tran et al. | An Efficient Synthesis of 5, 5′-(Tetradecane-1, 14-diyl) bis (2-methylbenzene-1, 3-diol) and Related Substances | |
| JP3843400B2 (en) | Process for producing alkyl monosubstituted hydroquinones | |
| JPS5912094B2 (en) | Synthesis method of chalcone bodies | |
| KR100426534B1 (en) | An improved synthetic method of azelastine | |
| KR100376280B1 (en) | Method for preparing cinnamaldehyde derivatives | |
| JPS5944313B2 (en) | Manufacturing method of indazole derivatives | |
| JPS598249B2 (en) | Synthesis method of chalcones | |
| SU615850A3 (en) | Method of obtaining substituted benzocycloalkanecarboxylic acid or its esters or amide |